Citius Oncology CTOR Cash Flow Statement (2022-2026)

NASDAQ CTOR
$0.67 -0.04 (-5.55%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Citius Oncology Quarterly Cash Flow Statement

Periods 15 quarters
Latest Jun 2026

Citius Oncology reported cash from operations of -$2.71M and free cash flow of -$2.71M for the quarter ended Jun 2026. This cash flow statement covers 15 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income 0.61M0.62M0.16M-4.73M-4.84M-4.77M-6.66M-7.74M-5.37M-5.00M-5.53M-26.61M-8.92M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles 0.57M1.72M1.72M
Amortization of Deferred ChargesAmort. Deferred Charges 0.18M
Share-based CompensationStock Comp. 1.92M1.96M1.96M1.81M2.09M2.13M2.30M3.96M3.53M3.56M
Deferred Taxes 0.14M0.26M0.26M0.26M0.26M0.26M-0.23M-0.11M
Change in Working Capital
Change in ReceivablesChange Receivables 4.05M-2.97M-0.39M
Change in InventoryChange Inventory 6.11M0.96M1.87M3.71M0.35M0.02M-0.03M
Change in Account PayablesChange Payables -1.08M2.16M1.80M0.99M4.57M-2.79M-1.56M-1.57M
Change in Accured ExpensesChange Accured Exp. 0.02M0.07M-0.20M0.11M0.00M6.23M2.49M-0.26M-4.37M0.43M19.54M0.02M
Change in Other Operating AssetsOther Assets Change 0.04M-0.03M0.04M-0.02M1.83M-0.11M-0.22M
Change in Other Operating LiabilitiesOther Liabilities Change 3.95M2.31M2.05M2.52M2.05M1.98M-3.27M1.76M
Other Working Capital ChangesOther WC Changes -0.04M0.03M3.95M-0.04M0.02M2.31M2.05M2.52M2.05M0.15M-3.16M1.99M
Cash from OperationsCash from Ops. -0.17M-0.10M-0.19M-0.37M-7.35M-3.83M-2.71M
Investing Activities
Change in IntangiblesChange Intangibless 4.40M0.60M2.00M
Purchase of InvestmentsInvestments Purchased 0.20M0.20M
Sale and Maturity of InvestmentsInvestments Sold 24.94M0.27M
Cash from Investing ActivitiesCash from Investing 24.74M0.07M-4.40M-0.60M-2.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.20M0.73M
Non-Current Debt 0.20M0.73M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.20M0.73M
Change in Capital Stock
Common Stock IssuedStock Issued 15.17M15.13M-0.06M9.73M
Net Shares Issued and RepurchasedNet Shares Issued 15.17M15.13M-0.06M9.73M
Net Equity Issued and RepurchasedNet Equity Issued 15.17M15.13M-0.06M9.73M
Other financing activitiesOther financing 0.19M-0.72M
Cash from Financing ActivitiesCash from Financing -24.55M0.26M15.13M-0.23M18.64M
Additional items
Change in Cash -0.17M0.25M584.00-0.03M3.37M-4.66M13.93M
Ending Cash Balance 0.29M0.12M0.37M0.03M0.03M0.03M261.00112.00112.00112.00112.003.92M7.30M2.63M16.56M
Free Cash FlowFCF -0.17M-0.10M-0.19M-0.37M-7.35M-3.83M-2.71M
Net Cash FlowNCF -0.17M-0.10M584.00-0.03M3.37M-4.66M13.93M
Interest Paid 0.01M0.20M

Citius Oncology Cash Flow Statement API

Pull Citius Oncology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CTOR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY